Orlando, FL (November 2014)— Did you know that November is National Lung Cancer Awareness Month? If you don’t, you’re not alone. Lung cancer is the number 1 cancer killer of men and women in the nation – taking more lives than colon, breast, and prostate cancer combined! Since awareness of these facts is limited, the American Lung Association’s LUNG FORCE Presented by Florida Hospital will be turning Central Florida turquoise to draw attention to the hold that lung cancer has upon local communities by hosting the LUNG FORCE Expo at SeaWorld.
Jennifer Williams had never smoked or even lived with anyone who smoked but was diagnosed with stage four lung cancer three years ago. Florida Hospital Thoracic Cancer Medical Director Dr. Tarek Mekhail put Jennifer on a clinical trail for a new lung cancer treatment and her cancer reduced by half. Jennifer is now on the second generation of this medication and is getting back to her normal life- including roller skating with her kids!
Minimally invasive, MRI-guided laser treatment is performed in Central Florida for the first time
ORLANDO, Fla., July, 3 2014 — Diane Bostick had tried everything to stop the tumor growing inside her brain with no success, that is until Florida Hospital neurosurgeon Dr. Melvin Field offered her a new kind of treatment. The new treatment Bostick received is called NeuroBlate and her procedure was the first of its kind in Central Florida.
ORLANDO, Fla., June 24, 2014 – Governor Rick Scott has announced the appointment of Florida Hospital Cancer Institute Executive Director Dr. David Decker to the James and Esther King Biomedical Research Advisory Council. He succeeds Dr. Claes Wahlestedt and his appointed term is June 11, 2014 through January 10, 2015.
The Biomedical Research program will support research initiatives addressing the health care concerns of Floridians including tobacco-related cancer, cardiovascular disease, stroke, and pulmonary disease.
Dr. Robert Holloway, a world-renowned Gynecologic Oncologist at the Florida Hospital Cancer Institute, visited physicians at the Brazilian National Cancer Institute Hospital and Samaritano Hospital Systems in Rio de Janeiro, Brazil this month. With robotic surgery for gynecology oncology being fairly new to Brazil, Dr. Holloway spent his time in Rio teaching lead surgeons on best practices for robotic surgeries.
Florida Hospital Cancer Institute is proud to bring the highlights of the ASCO Annual Meeting to you through its licensed Best of ASCO® meeting, to be held at the Buena Vista Palace Hotel, Lake Buena Vista, FL. Each year, the ASCO scientific committee selects the highest rated abstracts from the Annual Meeting to be available for licensed Best of ASCO meetings around the world. Florida Hospital Cancer Institute has chosen specific abstracts for presentation, based on the needs of our local oncology professionals.
Research conducted by Florida Hospital residents and fellows will be presented at the International Americas Hepato-Pancreato-Biliary Association (AHPBA) meeting.
ORLANDO, Fla., December 6, 2013 – For the second year in a row, research completed by Florida Hospital residents and fellows will be presented at the Americas Hepato-Pancreato-Biliary Association (AHPBA) meeting. This is an international meeting that occurs annually in February to bring together esteemed individuals from the Americas to present their novel research.
The adult stem cell transplant program has been recognized as an Optum Network Center of Excellence by the Clinical Sciences Institute of Optum